Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of HSV G207 and Radiation in Pediatric Recurrent High-Grade Glioma
NCT04482933Phase 2Withdrawn
- Sponsor
- Pediatric Brain Tumor Consortium
- Start
- Sep 2025
- Primary completion
- Dec 2025
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of G207 in glioma, sponsored by Pediatric Brain Tumor Consortium. Planned start Sep 2025; status: withdrawn.
02
Drugs
G207
03
Conditions
glioma
Beyond the preview
Go deeper on NCT04482933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04482933.